Form 8-K - Current report:
SEC Accession No. 0000950170-25-066426
Filing Date
2025-05-08
Accepted
2025-05-08 08:08:08
Documents
13
Period of Report
2025-05-08
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K mnkd-20250508.htm   iXBRL 8-K 43713
2 EX-99.1 mnkd-ex99_1.htm EX-99.1 364281
3 GRAPHIC img208524907_0.jpg GRAPHIC 27559
  Complete submission text file 0000950170-25-066426.txt   579394

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA WITH EMBEDDED LINKBASES DOCUMENT mnkd-20250508.xsd EX-101.SCH 25053
15 EXTRACTED XBRL INSTANCE DOCUMENT mnkd-20250508_htm.xml XML 4733
Mailing Address 1 CASPER STREET DANBURY CT 06810
Business Address 1 CASPER STREET DANBURY CT 06810 818-661-5000
MANNKIND CORP (Filer) CIK: 0000899460 (see all company filings)

EIN.: 133607736 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-50865 | Film No.: 25923997
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)